Weiss Ratings reiterated their sell (e+) rating on shares of 111 (NASDAQ:YI - Free Report) in a report published on Tuesday,Weiss Ratings reports.
111 Stock Up 11.4 %
Shares of 111 stock traded up $0.70 during mid-day trading on Tuesday, reaching $6.85. 39,085 shares of the stock traded hands, compared to its average volume of 23,142. The stock has a market capitalization of $58.58 million, a PE ratio of -1.71 and a beta of 0.57. The business has a 50-day moving average of $8.22 and a 200 day moving average of $7.52. 111 has a fifty-two week low of $4.15 and a fifty-two week high of $14.10.
111 (NASDAQ:YI - Get Free Report) last announced its quarterly earnings data on Thursday, March 20th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $527.14 million during the quarter.
Institutional Investors Weigh In On 111
Hedge funds and other institutional investors have recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its holdings in shares of 111 by 43,619.9% in the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company's stock worth $191,000 after acquiring an additional 305,339 shares during the last quarter. Napean Trading & Investment Co Singapore PTE Ltd purchased a new stake in 111 during the fourth quarter worth about $245,000. Finally, FIL Ltd acquired a new stake in shares of 111 during the fourth quarter worth about $450,000. 21.32% of the stock is currently owned by institutional investors and hedge funds.
111 Company Profile
(
Get Free Report)
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Featured Stories
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
